243 related articles for article (PubMed ID: 29736616)
41. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy.
Jolly MP; Jordan JH; Meléndez GC; McNeal GR; D'Agostino RB; Hundley WG
J Cardiovasc Magn Reson; 2017 Aug; 19(1):59. PubMed ID: 28768517
[TBL] [Abstract][Full Text] [Related]
42. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.
Armstrong GT; Plana JC; Zhang N; Srivastava D; Green DM; Ness KK; Daniel Donovan F; Metzger ML; Arevalo A; Durand JB; Joshi V; Hudson MM; Robison LL; Flamm SD
J Clin Oncol; 2012 Aug; 30(23):2876-84. PubMed ID: 22802310
[TBL] [Abstract][Full Text] [Related]
43. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
[TBL] [Abstract][Full Text] [Related]
44. Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk Scores.
Glen C; Adam S; McDowell K; Waterston A; Tan YY; Petrie MC; Coats CJ; Lang NN
JACC CardioOncol; 2023 Oct; 5(5):628-637. PubMed ID: 37969652
[TBL] [Abstract][Full Text] [Related]
45. MRI in cardio-oncology: A review of cardiac complications in oncologic care.
Jeong D; Gladish G; Chitiboi T; Fradley MG; Gage KL; Schiebler ML
J Magn Reson Imaging; 2019 Nov; 50(5):1349-1366. PubMed ID: 31448472
[TBL] [Abstract][Full Text] [Related]
46. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
47. Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.
Dhir V; Yan AT; Nisenbaum R; Sloninko J; Connelly KA; Barfett J; Haq R; Kirpalani A; Chan KKW; Petrella TM; Brezden-Masley C
Int J Cardiovasc Imaging; 2019 Nov; 35(11):2085-2093. PubMed ID: 31197526
[TBL] [Abstract][Full Text] [Related]
48. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
49. Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.
Schwartz RG; Jain D; Storozynsky E
J Nucl Cardiol; 2013 Jun; 20(3):443-64. PubMed ID: 23572315
[TBL] [Abstract][Full Text] [Related]
50. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
[TBL] [Abstract][Full Text] [Related]
52. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of left atrial remodeling using cardiovascular magnetic resonance imaging in breast cancer patients treated with adjuvant trastuzumab.
Huang F; Brezden-Masley C; Chan KKW; Barfett JJ; Kirpalani A; Deva DP; Jimenez-Juan L; Barthur A; Song L; Chacko B; Ng MY; Connelly K; Wong KCK; Yan AT
Eur Radiol; 2022 Jun; 32(6):4234-4242. PubMed ID: 34993574
[TBL] [Abstract][Full Text] [Related]
54. Applications of left ventricular strain measurements to patients undergoing chemotherapy.
Clasen SC; Scherrer-Crosbie M
Curr Opin Cardiol; 2018 Sep; 33(5):493-497. PubMed ID: 30028729
[TBL] [Abstract][Full Text] [Related]
55. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors.
Karakulak UN; Aladag E; Hekimsoy V; Sahiner ML; Kaya EB; Ozer N; Aksu S; Demiroglu H; Goker H; Buyukasik Y; Ozcebe O; Sayinalp N; Haznedaroglu IC
Cardiovasc Toxicol; 2021 Mar; 21(3):216-223. PubMed ID: 33068232
[TBL] [Abstract][Full Text] [Related]
56. LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review.
Printezi MI; Yousif LIE; Kamphuis JAM; van Laake LW; Cramer MJ; Hobbelink MGG; Asselbergs FW; Teske AJ
Curr Heart Fail Rep; 2022 Jun; 19(3):136-145. PubMed ID: 35355205
[TBL] [Abstract][Full Text] [Related]
57. Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies.
Ebrahimi A; Raichlen JS; Pointon A; Gottfridsson C; Munley J; Hockings P; Cartwright J; Buss N; Wikström J; Gan LM; Whittaker A; Khalil A; George RT; Garkaviy P; Brott D
Expert Opin Drug Saf; 2020 Mar; 19(3):281-294. PubMed ID: 32064957
[No Abstract] [Full Text] [Related]
58. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
59. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms.
Yagi R; Goto S; Himeno Y; Katsumata Y; Hashimoto M; MacRae CA; Deo RC
Nat Commun; 2024 Mar; 15(1):2536. PubMed ID: 38514629
[TBL] [Abstract][Full Text] [Related]
60. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]